About
Uri Lopatin is a physician-scientist and biotech entrepreneur who serves as CEO at Ukko. He also works as a founder, board member, and investor.
Experience
- UkkoCEOcurrent2024 β present
- Khosla VenturesOperating Partnercurrent2023 β presentSan Francisco Bay Area
- Edmund Hillary Fellowship (EHF)Fellowcurrent2020 β present
- Pardes BiosciencesFounder, Board Member, Strategic and Scientific Advisor2022 β 2023
- Pardes BiosciencesFounder, CEO and President2020 β 2022San Francisco Bay Area
- Y CombinatorExpert - Bio2020 β 2023San Francisco Bay Area
- Y CombinatorVisiting Partner2019 β 2020San Francisco Bay Area
- Assembly Biosciences, Inc.Scientific & Strategic Advisor2019 β 2022San Francisco Bay Area
- Assembly Biosciences, Inc.Co-Founder & Chief Medical Officer2012 β 2019San Francisco/IN
- StartX MedMentor2012 β 2019
- Thiel 20 under 20 FellowshipMentor2013 β 2016
- YoseraFounder & CEO2012 β 2015San Francisco
- The Center for Biosecurity - UPMCFellow - Emerging Leaders in Biosecurity Initiative2013 β 2015
- Assembly PharmaceuticalsCo-Founder/Chief Medical Officer/VP R&D2012 β 2014
- Gilead SciencesSenior Director, Clinical and Translational Research2010 β 2012
- Roche PharmaceuticalsTranslational Medicine Leader2008 β 2010Palo alto, Ca
- Schering-Plough Research InstituteAssociate Director: Hepatology2007 β 2008
- National Institutes of HealthPhysician-Scientist: Infectious Disease Fellowship and Mucosal Immunology Research2003 β 2007
- NYUResident2002 β 2003
- UMDNJ-NJMSMedical Student1994 β 2000
Education
- National Institutes of HealthID Fellowship2003 β 2006
- New York UniversityResidency, Internal Medicine Residency Program2001 β 2003
- University of Washington - School of MedicineInternship2000 β 2001
- University of Medicine and Dentistry of New Jersey -New Jersey Medical SchoolMD, Medicine1994 β 2000
- Cornell UniversityBA, Biology1990 β 1994
- Ramaz1985 β 1989
Skills & more
CTMS3R2Clinical Trials99Immunology99Clinical Development47Infectious Diseases99Clinical Research62Translational Research32Translational Medicine39Biomarkers62Lifesciences15Biotechnology99
+12 more
VirologyCancerDrug DevelopmentMolecular BiologyPharmacokineticsMedical WritingOncologyPharmaceutical IndustryPharmacologyLeadershipINDGCPLanguages Spanish Β· Yiddish
From Uri's professional profile.
Same school
Also attended New York University281
Gabriella GiglioHR & Executive Talent at General CatalystAndrea EchstenkamperVP of Marketing at HeavybitRami BranitzkyPartner at Sapphire VenturesZach WhiteInvestment Team at 8VCAnkita TiwariPrograms Manager at StartXJohann FriederichAssociate at Notion Capital
+ 275 more
Also attended University of Washington - School of Medicine9
Dennis SchmulandInvestor at EPIC VENTURESDavid CohnInterim Chief Executive Officer and Chief Medical Officer at Oncology VenturesChing-Ping LinPartner & COO at Orbit StartupsJulien PhamFounder & Managing Partner at 3CC | Third Culture CapitalMitch GoldVenture Partner at Frazier Life SciencesAmy PollackIndependent Consultant and Board Member at Foreground Capital
+ 3 more
Also attended University of Medicine and Dentistry of New Jersey -New Jersey Medical School1
Also attended Cornell University509
Doug LeonePartner at Sequoia Capital; former Global Managing PartnerJenny LeeSenior Managing Partner at Granite AsiaNeeraj AgrawalGeneral Partner at Battery VenturesMichelle FernandesInvestor at Index VenturesMicah RosenbloomGeneral Partner at Founder CollectiveAlexandra FarmerPrincipal at Intel Capital, North America
+ 503 more
Shared employers
Also worked at Edmund Hillary Fellowship (EHF)25
Jeffrey PaineFounding Partner at Golden Gate VenturesTony LaiInvestor at StartXRyan McIntyreFounding partner of FoundryAmitt MahajanManaging Partner at Presence CapitalGeoff LewisFounder & Managing Partner at BedrockTory PattersonCo-founder and Managing Partner at Owl Ventures
+ 19 more
Also worked at Y Combinator66
Garry TanPresident & CEO of Y CombinatorJessica LivingstonCo-founder of Y CombinatorAlexis OhanianFounder & General Partner of Seven Seven SixMichael SeibelPartner Emeritus at Y CombinatorDalton CaldwellCo-founder of Standard Capital; Partner Emeritus at Y CombinatorHarj TaggarGeneral Partner at Y Combinator
+ 60 more
Also worked at Gilead Sciences20
Jay ParrishVenture Partner at ARCH Venture PartnersPatrick LoerchBio Advisor at Amplify PartnersLan WuAnalyst at FusionAriel RahamimPrincipal at Concept VenturesMuz MansuriAdvisor at Delin VenturesXavier AvatChief Business Officer at Oncology Ventures
+ 14 more
Also worked at Roche Pharmaceuticals75
Joseph HorsmanInvestor at Madrona Venture GroupMarco PrunottoInvestor at MedicxiMike FitzgeraldInvestor at High AlphaJan-Olivier FillolsSenior Managing Director at Marlin Equity PartnersNarges BaniasadiVenture Partner at Think+ Ventures Management, LlcAlex MaywegManaging Director at Versant Ventures
+ 69 more
Colleagues at Khosla Ventures
Adina Tecklu
Investor at Khosla Ventures
Adrian Radu
Investor at Khosla Ventures
Alex Morgan
Investor at Khosla Ventures
Alice Brooks
Investor at Khosla Ventures
Amy Kalokerinos
Investor at Khosla Ventures
Anne Foor
Investor at Khosla Ventures
Austin Hay
Investor at Khosla Ventures
Avisha Mehra Naganath
Investor at Khosla Ventures




























.png)















